MedPath

ALLERGAN MEDICAL

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Completed
Conditions
Lip Augmentation
Interventions
Device: Crosslinked hyaluronic acid gel
First Posted Date
2012-06-27
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
62
Registration Number
NCT01629134

Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement

Not Applicable
Completed
Conditions
Lip Volume Enhancement
Interventions
Device: Juvéderm® Volbella with Lidocaine
Device: Restylane-L®
First Posted Date
2012-04-17
Last Posted Date
2019-01-17
Lead Sponsor
Allergan Medical
Target Recruit Count
285
Registration Number
NCT01579305

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Completed
Conditions
Age-related Volume Deficit in the Mid-face
Interventions
Device: Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®)
First Posted Date
2012-03-21
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
115
Registration Number
NCT01559064

Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement

Not Applicable
Completed
Conditions
Lip Enhancement
Interventions
Device: hyaluronic acid gel
First Posted Date
2010-08-06
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
62
Registration Number
NCT01176773

European Union (EU) Post-Market Study on Easyband®

Completed
Conditions
Morbid Obesity
Interventions
Device: Easyband®
First Posted Date
2009-07-29
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
112
Registration Number
NCT00948246

Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds

Phase 4
Completed
Conditions
Nasolabial Folds
Interventions
Device: Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine
Device: A gel of hyaluronic acid (concentration of 20 mg/mL)
First Posted Date
2009-02-25
Last Posted Date
2019-01-09
Lead Sponsor
Allergan Medical
Target Recruit Count
32
Registration Number
NCT00850889

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Not Applicable
Completed
Conditions
Breast Reconstruction
Interventions
Device: Natrelle(TM) Silicone-Filled Breast Implants
First Posted Date
2008-06-05
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
84329
Registration Number
NCT00691327

Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Not Applicable
Completed
Conditions
Breast Augmentation
Revision of Augmentation or Reconstruction
Breast Reconstruction
Interventions
Device: Natrelle(TM) Silicone-Filled Breast Implants
First Posted Date
2008-06-04
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
715
Registration Number
NCT00689871

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

Not Applicable
Completed
Conditions
Breast Augmentation
Revision of Augmentation or Reconstruction
Breast Reconstruction
Interventions
Device: Style 410 Silicone-Filled Breast Implants
First Posted Date
2008-06-04
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
941
Registration Number
NCT00690339

Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine

Not Applicable
Completed
Conditions
Nasolabial Folds
Interventions
Device: JUVÉDERM™ Injectable Gel
Device: JUVÉDERM™ Injectable Gel with Lidocaine
First Posted Date
2008-04-07
Last Posted Date
2014-10-13
Lead Sponsor
Allergan Medical
Target Recruit Count
72
Registration Number
NCT00653861
© Copyright 2025. All Rights Reserved by MedPath